Glory Health Industry Limited (HKG:2329)

Glory Health Industry Statistics

Total Valuation

HKG:2329 has a market cap or net worth of HKD 533.33 million. The enterprise value is 27.91 billion.

Market Cap	533.33M
Enterprise Value	27.91B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2329 has 4.44 billion shares outstanding.

Current Share Class	4.44B
Shares Outstanding	4.44B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	76.71%
Owned by Institutions (%)	n/a
Float	1.03B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	0.04
P/TBV Ratio	0.05
P/FCF Ratio	0.46
P/OCF Ratio	0.46
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.10
EV / Sales	12.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	24.20

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 1.85.

Current Ratio	1.03
Quick Ratio	0.32
Debt / Equity	1.85
Debt / EBITDA	n/a
Debt / FCF	21.47
Interest Coverage	-0.11

Financial Efficiency

Return on equity (ROE) is -11.74% and return on invested capital (ROIC) is -0.31%.

Return on Equity (ROE)	-11.74%
Return on Assets (ROA)	-0.12%
Return on Invested Capital (ROIC)	-0.31%
Return on Capital Employed (ROCE)	-0.42%
Weighted Average Cost of Capital (WACC)	3.54%
Revenue Per Employee	5.75M
Profits Per Employee	-3.96M
Employee Count	389
Asset Turnover	0.04
Inventory Turnover	0.09

Taxes

In the past 12 months, HKG:2329 has paid 23.67 million in taxes.

Income Tax	23.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.44% in the last 52 weeks. The beta is 0.16, so HKG:2329's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+30.44%
50-Day Moving Average	0.12
200-Day Moving Average	0.12
Relative Strength Index (RSI)	43.79
Average Volume (20 Days)	268,250

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2329 had revenue of HKD 2.24 billion and -1.54 billion in losses. Loss per share was -0.35.

Revenue	2.24B
Gross Profit	139.88M
Operating Income	-118.81M
Pretax Income	-1.64B
Net Income	-1.54B
EBITDA	-55.58M
EBIT	-118.81M
Loss Per Share	-0.35

Balance Sheet

The company has 115.61 million in cash and 24.76 billion in debt, with a net cash position of -24.64 billion or -5.54 per share.

Cash & Cash Equivalents	115.61M
Total Debt	24.76B
Net Cash	-24.64B
Net Cash Per Share	-5.54
Equity (Book Value)	13.37B
Book Value Per Share	2.39
Working Capital	874.71M

Cash Flow

In the last 12 months, operating cash flow was 1.15 billion and capital expenditures 1.85 million, giving a free cash flow of 1.15 billion.

Operating Cash Flow	1.15B
Capital Expenditures	1.85M
Free Cash Flow	1.15B
FCF Per Share	0.26

Margins

Gross margin is 6.25%, with operating and profit margins of -5.31% and -68.90%.

Gross Margin	6.25%
Operating Margin	-5.31%
Pretax Margin	-73.43%
Profit Margin	-68.90%
EBITDA Margin	-2.48%
EBIT Margin	-5.31%
FCF Margin	51.54%

Dividends & Yields

HKG:2329 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-289.07%
FCF Yield	216.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2329 has an Altman Z-Score of 0.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	3